Dthera Sciences engages in the development of digital therapeutic technology. It designed to deliver reminiscence therapy to patients suffering from Alzheimer's disease. The company was founded on December 27, 2012 and is headquartered in San Diego, CA.
Company profile
Ticker
DTHR
Exchange
Website
CEO
Edward M. Cox
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Knowledge Machine International, Inc., Songbird Development Inc.
SEC CIK
Corporate docs
Latest filings (excl ownership)
SEC STAFF ACTION
SEC staff action: Order
6 Aug 19
8-K
Entry into a Material Definitive Agreement
22 Feb 19
UPLOAD
Letter from SEC
4 Dec 18
CORRESP
Correspondence with SEC
19 Nov 18
10-Q
2018 Q3
Quarterly report
14 Nov 18
CORRESP
Correspondence with SEC
9 Nov 18
8-K
Departure of Directors or Certain Officers
31 Oct 18
UPLOAD
Letter from SEC
24 Oct 18
8-K
Dthera Sciences Announces Reverse Split
27 Sep 18
S-1
IPO registration
27 Sep 18
Latest ownership filings
No filings